Khurshid, Shaan http://orcid.org/0000-0002-2840-4539
Weng, Lu-Chen
Nauffal, Victor
Pirruccello, James P.
Venn, Rachael A.
Al-Alusi, Mostafa A.
Benjamin, Emelia J. http://orcid.org/0000-0003-4076-2336
Ellinor, Patrick T. http://orcid.org/0000-0002-2067-0533
Lubitz, Steven A. http://orcid.org/0000-0002-9599-4866
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL139731, T32HL007604, R01HL092577, R01HL141434, R01AG066010, 1R01AG066914, 2U54HL120163, 1RO1HL092577, K24HL105780)
American Heart Association (18SFRN34250007, 18SFRN34110082, 18SFRN34110082, 18SFRN34110082)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Article History
Received: 1 March 2022
Accepted: 10 August 2022
First Online: 2 September 2022
Competing interests
: S.A.L. is a full-time employee of Novartis as of July 18, 2022. S.A.L. has received sponsored research support from Bristol Myers Squibb, Pfizer, Boehringer Ingelheim, Fitbit, Medtronic, Premier, and IBM, and has consulted for Bristol Myers Squibb, Pfizer, Blackstone Life Sciences, and Invitae. P.T.E. receives sponsored research support from Bayer AG and IBM Health and he has consulted for Bayer AG, Novartis, MyoKardia, and Quest Diagnostics. The remaining authors declare no competing interests.